L Gandolfi, P Leo, L Solmi, E Vitelli, G Verros, A Colecchia Abstract Hepatic haemangiomas are the most common benign tumours of the liver and commonly present as incidental findings on sonographic examination of the abdomen. Since little is known of the natural course of these tumours, we performed a clinical and sonographic follow up of 123 haemangioma patients. Our prospective study investigated clinical and sonographic findings in 158 haemangiomas for periods of 12 to 60 months. Ninety nine haemangiomas measured <2 cm and had an echogenic pattern; 40 were between 2 cm and 5 cm with a mainly echogenic structure; 19 measured >5 cm and showed a mixed echo pattern. At the first examination only eight patients, all with giant haemangiomas, presented symptoms which could be attributed to the tumour. During follow up only one haemangioma changed in shape and size. One laparoscopy). The remaining seven haemangiomas were diagnosed according to the above clinical, biochemical, and sonographic criteria; none of these patients had a past history of malignancy.
In all 17 patients with giant haemangiomas the final diagnosis was made by computed tomography (nine cases), 99mTc-red blood cell radionuclide scans (six cases), laparoscopy (four cases), and angiography (four cases). Some patients were subjected to more than one imaging technique.
Ultrasonography was performed with an SSD Aloka 256 real time scanner using a 3.5 MHz linear transducer; images were recorded by Polaroid. At least three transverse, longitudinal, and anteroposterior measurements were taken of each lesion. When none of the three diameters coincided with the maximum diameter of the haemangioma a section containing the maximum diameter was measured. Changes in size within an upper or lower limit of 2 mm were not considered important owing to the measurement limitations of the equipment.
Clinical and sonographic follow up was performed in all patients at three and six months in the first year and annually thereafter.
Results
The male:female ratio of the 123 haemangioma patients in the follow up study was 1:2. This ratio was not significantly different from that found in the 292 patients found to have haemangioma (95% confidence interval). Average age was In the group of giant haemangiomas (diameter over 5 cm) the sonographic features changed in one man during the third year of follow up. The maximum diameter of his lesion had increased by 1 5 cm and wide echo free areas were present in the middle of the haemangioma (Fig 2) . This enlargement was confirmed by computed tomography with bolus infusion of contrast medium compared with the previous scan three years earlier. In the other 16 patients the sonograms were unchanged.
CLINICAL FOLLOW UP
All the haemangiomas under 2 cm or between 2 cm and 5 cm were found incidentally during ultrasound examination, usually during screening for liver metastases in cancer patients or for suspected biliary disease. During follow up none of these patients presented symptoms which could be correlated with the haemangioma.
Eight of the 17 patients with hepatic haemangiomas over 5 cm were symptomatic at the first examination: seven reported discomfort in the right upper abdominal quadrant and feelings of fullness (but three of these also had gall bladder lithiasis); one patient presented with an episode of abdominal pain with fever, slight jaundice, and choluria (the lesion was located in segment IV). The other nine patients were asymptomatic at the first examination, although five had clinically evident hepatomegaly and in two an abdominal mass was palpable. The other three patients screened presented no symptoms or clinical signs at the first examination.
During follow up, eight of the nine asymptomatic patients remained symptom free. One patient experienced an acute episode of pain in the right upper abdominal quadrant during physical exercise, which lasted several hours and was accompanied by raised activity of hepatic enzymes of cholestasis and cytolysis. Ultrasonography disclosed no changes in size or echo pattern and biochemical parameters soon normalised.
Symptoms subsided in six of the eight patients with giant lesions who were symptomatic at the first examination. The patient with abdominal pain and choluria has not had recurrent episodes during a three year follow up even though his haemangioma had increased in diameter. Symptoms remained unchanged in two patients but their quality of life has been acceptable. During follow up none of the patients with a giant haemangioma had major complications such as bleeding, rupture, fever, or thrombocytopenia.
Discussion
Haemangiomas are the most common benign liver tumours,'0 with a prevalence varying from 1.4% to 2-3% in necropsy, surgical,'211 or, more recently, ultrasonographic series.'2 In our series the prevalence was found to be 1-4%.
The diagnostic problems related to the frequent occurrence of this tumour have been largely resolved by state of the art imaging techniques (computed tomography and ultrasonography).79 '3 Above all, ultrasonography has provided a great deal of information on the natural course of these lesions of which little has been known because of the lack of published reports.8 14 The male:female ratio of the patients in our clinical and ultrasonographic follow up was 1:2, in agreement with other series'3 1 ' but lower than reported by other workers who noted a female prevalence of up to 5: 1. 3 Incidental detection of haemangiomas is most common in the third, fourth, and fifth decades of life. 16 In our series the average age was similar for men (56.7 years) and women (52.3 years). Considering only those patients with so called giant haemangiomas (diameter over 5 cm), the average age at detection was a decade lower in women than in men, as reported by Trastek et al. 14 The results of our follow up and those in recent studies reporting few complications814 raise the question of whether the risks of surgically resecting giant asymptomatic haemangiomas outweigh the risks of haemorrhage or enlargement. In fact, surgical management carries some degree of risk.'420242728 So far alternative therapeutic approaches, such as hepatic artery ligation or embolisation, have failed to shrink haemangiomas or improve symptoms and they carry the risk of ischaemia and infection.14 26 29 Our study shows that prolonged ultrasound follow up of small and medium sized haemangiomas is not warranted. Short term follow up (6-12 months) is useful when the final diagnosis has not been established by other techniques in order to differentiate the haemangioma from malignant lesions, especially secondary tumours in cancer patients.
